Cumulative Viral Load and Virologic Decay Patterns after Antiretroviral Therapy in HIV-Infected Subjects Influence CD4 Recovery and AIDS

• Vincent C. Marconi ,

  * E-mail: vcmarco@emory.edu (VCM); kulkarnih@uthscsa.edu (HK)

  Affiliations Division of Infectious Diseases, Emory University School of Medicine, Atlanta, Georgia, United States of America, Infectious Disease Clinical Research Program, Uniformed Services University of the Health Sciences, Bethesda, Maryland, United States of America

  ⨯
• Greg Grandits,

  Affiliations Infectious Disease Clinical Research Program, Uniformed Services University of the Health Sciences, Bethesda, Maryland, United States of America, Division of Biostatistics, University of Minnesota, Minneapolis, Minnesota, United States of America

  ⨯
• Jason F. Okulicz,

  Affiliations Infectious Disease Clinical Research Program, Uniformed Services University of the Health Sciences, Bethesda, Maryland, United States of America, Infectious Disease Service, San Antonio Military Medical Center, Brooke Army Medical Center, Fort Sam Houston, Texas, United States of America

  ⨯
• Glenn Wortmann,

  Affiliations Infectious Disease Clinical Research Program, Uniformed Services University of the Health Sciences, Bethesda, Maryland, United States of America, Infectious Disease Service, Walter Reed Army Medical Center, Washington, D.C., United States of America

  ⨯
• Anuradha Ganesan,

  Affiliations Infectious Disease Clinical Research Program, Uniformed Services University of the Health Sciences, Bethesda, Maryland, United States of America, Infectious Disease Clinic, National Naval Medical Center, Bethesda, Maryland, United States of America

  ⨯
• Nancy Crum-Cianflone,

  Affiliations Infectious Disease Clinical Research Program, Uniformed Services University of the Health Sciences, Bethesda, Maryland, United States of America, Infectious Disease Clinic, Naval Medical Center San Diego, San Diego, California, United States of America

  ⨯
• Michael Polis,

  Affiliations Infectious Disease Clinical Research Program, Uniformed Services University of the Health Sciences, Bethesda, Maryland, United States of America, National Institute for Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America

  ⨯
• Michael Landrum,

  Affiliations Infectious Disease Clinical Research Program, Uniformed Services University of the Health Sciences, Bethesda, Maryland, United States of America, Infectious Disease Service, San Antonio Military Medical Center, Brooke Army Medical Center, Fort Sam Houston, Texas, United States of America

  ⨯
• Matthew J. Dolan,

  Affiliation Henry M. Jackson Foundation, Wilford Hall United States Air Force Medical Center, Lackland Air Force Base, Texas, United States of America

  ⨯
• Sunil K. Ahuja,

  Affiliations Veterans Administration Research Center for AIDS and HIV-1 Infection, South Texas Veterans Health Care System, San Antonio, Texas, United States of America, Department of Medicine, University of Texas Health Science Center, San Antonio, Texas, United States of America, Department of Microbiology and Immunology, and Biochemistry, University of Texas Health Science Center, San Antonio, Texas, United States of America

  ⨯
• Brian Agan,

  Affiliation Infectious Disease Clinical Research Program, Uniformed Services University of the Health Sciences, Bethesda, Maryland, United States of America

  ⨯
• Hemant Kulkarni ,

  * E-mail: vcmarco@emory.edu (VCM); kulkarnih@uthscsa.edu (HK)

  Affiliations Veterans Administration Research Center for AIDS and HIV-1 Infection, South Texas Veterans Health Care System, San Antonio, Texas, United States of America, Department of Medicine, University of Texas Health Science Center, San Antonio, Texas, United States of America

  ⨯
• the Infectious Disease Clinical Research Program (IDCRP) HIV Working Group

  ¶Membership of the IDCRP HIV Working Group is provided in the Acknowledgments.

  ⨯